A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis

2012 ◽  
Vol 32 (1) ◽  
pp. 99-108 ◽  
Author(s):  
Xiao-Xiang Chen ◽  
Qing Dai ◽  
An-Bin Huang ◽  
Hua-Xiang Wu ◽  
Dong-Bao Zhao ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Combination Therapy ◽  
Fusion Protein ◽  
Chinese Patients ◽  
Severe Rheumatoid Arthritis ◽  
Double Blind ◽  
Double Blind Clinical Trial

Effects of Probiotic Supplementation on Oxidative Stress Indices in Women with Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial

2015 ◽  
Vol 35 (4) ◽  
pp. 291-299 ◽  
Author(s):  
Elnaz Vaghef-Mehrabany ◽  
Aziz Homayouni-Rad ◽  
Beitullah Alipour ◽  
Sakineh-Khatoun Sharif ◽  
Leila Vaghef-Mehrabany ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Oxidative Stress ◽  
Clinical Trial ◽  
Probiotic Supplementation ◽  
Double Blind ◽  
Stress Indices ◽  
Double Blind Clinical Trial

A Long Term Double-Blind Clinical Trial of Ibuprofen and Indomethacin in Rheumatoid Arthritis

1975 ◽  
Vol 3 (3) ◽  
pp. 158-171 ◽  
Author(s):  
G L Royer ◽  
T E Moxley ◽  
M S Hearron ◽  
A Miyara ◽  
B M Shenker
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Side Effects ◽  
Double Blind ◽  
Double Blind Clinical Trial

Two-hundred and eighteen individuals with rheumatoid arthritis were randomly assigned to six months treatment with ibuprofen (900-1800 mg/day) or indomethacin (75-150 mg/day). The drugs were equally effective in the treatment of rheumatoid arthritis while the incidence of indomethacin side-effects was 1·5 times greater than the incidence of ibuprofen side-effects.

Sign in / Sign up

Export Citation Format

Share Document